Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches
Psoriasis is an immune-mediated inflammatory disease, with a chronic relapsing-remitting course, which affects 2–3% of the worldwide population. The progressive acquisitions of the inflammatory pathways involved in the development of psoriasis have led to the identification of the key molecules of t...
Guardado en:
Autores principales: | Anna Campanati, Andrea Marani, Emanuela Martina, Federico Diotallevi, Giulia Radi, Annamaria Offidani |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/16c73e2b3e974af0b68bc99a31453b9d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Erythrodermic psoriasis: pathophysiology and current treatment perspectives
por: Singh RK, et al.
Publicado: (2016) -
Psoriasis and systemic lupus erythematosus in children – literature review based on case report
por: Izabela Dybowska-Gołota, et al.
Publicado: (2020) -
Common Fundamentals of Psoriasis and Depression
por: Stefanie Hölsken, et al.
Publicado: (2021) -
Local effects of adipose tissue in psoriasis and psoriatic arthritis
por: Kruglikov IL, et al.
Publicado: (2017) -
Management of scalp psoriasis: current perspectives
por: Blakely K, et al.
Publicado: (2016)